Provided by Tiger Fintech (Singapore) Pte. Ltd.

Arcus Biosciences Inc.

8.53
-0.2700-3.07%
Volume:185.24K
Turnover:1.57M
Market Cap:903.20M
PE:-2.03
High:8.82
Open:8.82
Low:8.34
Close:8.80
Loading ...

Arcus Biosciences, Inc.'s (NYSE:RCUS) latest 8.6% decline adds to one-year losses, institutional investors may consider drastic measures

Simply Wall St.
·
29 Mar

Analysts Have Conflicting Sentiments on These Healthcare Companies: Arcus Biosciences (RCUS), aTyr Pharma (ATYR) and Lyra Therapeutics (LYRA)

TIPRANKS
·
14 Mar

Little Excitement Around Arcus Biosciences, Inc.'s (NYSE:RCUS) Revenues As Shares Take 26% Pounding

Simply Wall St.
·
06 Mar

Stock Track | Arcus Biosciences (RCUS) Plummets 5.05% as Insider Funding Fails to Boost Investor Confidence

Stock Track
·
04 Mar

Arcus Biosciences (RCUS): Among Stocks With At Least $10 Million In Insider Spending Recently

Insider Monkey
·
04 Mar

Morgan Stanley Remains a Buy on Arcus Biosciences (RCUS)

TIPRANKS
·
03 Mar

Insider Buying: Arcus Biosciences Co-Founder Bought US$201k Of Shares

Simply Wall St.
·
02 Mar

Arcus Biosciences, Inc. (NYSE:RCUS) Analysts Are Cutting Their Estimates: Here's What You Need To Know

Simply Wall St.
·
28 Feb

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Sarepta Therapeutics (SRPT), Arcus Biosciences (RCUS) and Certara (CERT)

TIPRANKS
·
27 Feb

Arcus Biosciences to Participate in Two Upcoming Investor Conferences

Business Wire
·
27 Feb

BUZZ-U.S. STOCKS ON THE MOVE-Cheesecake Factory, SiriusPoint, Arcutis Biosciences

Reuters
·
27 Feb

BUZZ-Arcus Biosciences gains after H.C. Wainwright upgrades to "buy"

Reuters
·
26 Feb

Stock Track | Arcus Biosciences Soars 13.38% as Analysts Upgrade Stock and Raise Price Targets

Stock Track
·
26 Feb

Arcus Biosciences Raised to Buy From Neutral by HC Wainwright & Co.

Dow Jones
·
26 Feb

HC Wainwright Upgrades Arcus Biosciences to Buy From Neutral, Adjusts Price Target to $24 From $18

MT Newswires Live
·
26 Feb

Arcus Biosciences Inc : H.c. Wainwright Raises to Buy From Neutral; Raises Target Price to $24

THOMSON REUTERS
·
26 Feb

Arcus Biosciences (RCUS) Receives a Buy from Barclays

TIPRANKS
·
26 Feb

Arcus Biosciences, Inc. (RCUS) Reports Q4 Loss, Tops Revenue Estimates

Zacks
·
26 Feb

Arcus Biosciences Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
26 Feb

Arcus Biosciences Q4 EPS $(1.03) Beats $(1.32) Estimate, Sales $36.00M Beat $28.90M Estimate

Benzinga
·
26 Feb